3055 A prognostic model for platinum-doublet regimens as second-line chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients. (September 2015) - Shi, Y.; Mo, H.; Hao, X.; Liu, Y.; Wang, L.; Hu, X.; Xu, J.; Yang, S.; Xing, P.; Shi, Y.; Jia, B.; Wang, Y.; et al.